Cargando…

Healthcare costs related to adverse events in hepatocellular carcinoma treatment: A retrospective observational claims study

BACKGROUND: Hepatocellular carcinoma (HCC) is an aggressive form of liver cancer with increasing incidence and mortality worldwide. For metastatic disease, systemic treatment is recommended. In addition to tumor characteristics, adverse events (AEs) may influence regimen choice. AIM: To analyze heal...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lal, Lincy S., Aly, Abdalla, Le, Lisa B., Peckous, Susan, Seal, Brian, Teitelbaum, April
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9124510/ https://www.ncbi.nlm.nih.gov/pubmed/34494389 http://dx.doi.org/10.1002/cnr2.1504

Ejemplares similares

Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USA
por: Aly, Abdalla, et al.
Publicado: (2021)

Retrospective claims analysis of best supportive care costs and survival in a US metastatic renal cell population
por: Henk, Henry J, et al.
Publicado: (2013)

Treatment patterns and outcomes in pancreatic cancer: Retrospective claims analysis
por: Doleh, Yunes, et al.
Publicado: (2020)

Clinical Characteristics, Treatment Patterns, and Healthcare Costs and Utilization for Hepatocellular Carcinoma (HCC) Patients Treated at a Large Referral Center in Washington State 2007–2018
por: Shankaran, Veena, et al.
Publicado: (2021)

The Impact of Adverse Events on Health Care Resource Utilization, Costs, and Mortality Among Patients Treated with Immune Checkpoint Inhibitors
por: George, Saby, et al.
Publicado: (2021)

Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods
por: Aly, Abdalla, et al.
Publicado: (2015)

Comparison Of Methods To Estimate Disease-Related Cost And Healthcare Resource Utilization For Autoimmune Diseases In Administrative Claims Databases
por: Schroeder, Krista M, et al.
Publicado: (2019)

To what extent are adverse events found in patient records reported by patients and healthcare professionals via complaints, claims and incident reports?
por: Christiaans-Dingelhoff, Ingrid, et al.
Publicado: (2011)

Eltrombopag treatment of patients with secondary immune thrombocytopenia: retrospective EHR analysis
por: Patwardhan, Pallavi, et al.
Publicado: (2021)

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis
por: Best, Jennie H, et al.
Publicado: (2019)

Hepatocellular carcinoma after prior sorafenib treatment: incidence, healthcare utilisation and costs from German statutory health insurance claims data
por: Clouth, Johannes, et al.
Publicado: (2018)

Changing Job Satisfaction, Absenteeism, and Healthcare Claims Costs In a Hospital Culture
por: Newsome, Misty, et al.
Publicado: (2014)

Healthcare costs and resource utilization of asthma in Germany: a claims data analysis
por: Jacob, Christian, et al.
Publicado: (2015)

Healthcare Resource Utilization and Costs in Celiac Disease: A US Claims Analysis
por: Cappell, Katherine, et al.
Publicado: (2020)

Psoriasis and Major Adverse Cardiovascular Events: A Systematic Review and Meta‐Analysis of Observational Studies
por: Armstrong, Ehrin J., et al.
Publicado: (2013)

Clinical outcomes by Child-Pugh Class in patients with advanced hepatocellular carcinoma in a community oncology setting
por: Aly, Abdalla, et al.
Publicado: (2023)

Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns
por: Foley, K. A., et al.
Publicado: (2010)

Surveillance and compensation claims for adverse events following immunization from 2011 to 2016 in the Republic of Korea
por: Kim, Min-Kyung, et al.
Publicado: (2017)

Attribution of Adverse Events Following Coronary Stent Placement Identified Using Administrative Claims Data
por: Dhruva, Sanket S., et al.
Publicado: (2020)

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database
por: Shima, Daisuke, et al.
Publicado: (2020)

Real-world Treatment Patterns and Reasons for Therapy Selection in Patients with Advanced Hepatocellular Carcinoma in US Oncology Practices
por: Klink, Andrew J, et al.
Publicado: (2022)

Healthcare costs of patients on different renal replacement modalities – Analysis of Dutch health insurance claims data
por: Mohnen, Sigrid M., et al.
Publicado: (2019)

Healthcare costs and utilization of diabetes-related complications in Taiwan: A claims database analysis
por: Cheng, Ssu-Wei, et al.
Publicado: (2018)

Medication Adherence and Healthcare Costs in Chronically Ill Patients Using German Claims Data
por: Wendl, Johannes, et al.
Publicado: (2023)

Management of hepatocellular carcinoma from diagnosis in routine clinical practice
por: Lokhandwala, Tasneem, et al.
Publicado: (2023)

The Burden of Preventable Adverse Drug Events on Hospital Stay and Healthcare Costs in Japanese Pediatric Inpatients: The JADE Study
por: Iwasaki, Hitoshi, et al.
Publicado: (2021)

Healthcare costs for the elderly in Japan: Analysis of medical care and long-term care claim records
por: Akiyama, Naomi, et al.
Publicado: (2018)

Costs and repeat rates associated with colonoscopy observed in medical claims for commercial and Medicare populations
por: Pyenson, Bruce, et al.
Publicado: (2014)

Direct medical costs of adverse events in Dutch hospitals
por: Hoonhout, Lilian HF, et al.
Publicado: (2009)

Assessment of costs associated with adverse events in patients with cancer
por: Wong, William, et al.
Publicado: (2018)

Costs associated with adverse events among acute patients
por: Kjellberg, Jakob, et al.
Publicado: (2017)

Metabolic Acidosis and Adverse Outcomes and Costs in CKD: An Observational Cohort Study
por: Reaven, Nancy L., et al.
Publicado: (2023)

The average cost of measles cases and adverse events following vaccination in industrialised countries
por: Carabin, Hélène, et al.
Publicado: (2002)

A Review of Immune-Mediated Adverse Events in Melanoma
por: Kennedy, Lucy Boyce, et al.
Publicado: (2019)

The three-part model for coding causes and mechanisms of healthcare-related adverse events
por: Southern, Danielle A., et al.
Publicado: (2022)

Immune checkpoint inhibitors: immune-related adverse events, healthcare utilization, and costs among commercial and Medicare Advantage patients
por: Gunturu, Krishna S., et al.
Publicado: (2022)

Compliance with Pharmacotherapy and Direct Healthcare Costs in Patients with Parkinson’s Disease: A Retrospective Claims Database Analysis
por: Richy, Florent F., et al.
Publicado: (2013)

Healthcare Utilization and Costs associated with Hereditary Hemorrhagic Telangiectasia Patients in a Large US Claims Database
por: Hasan Albitar, Hasan Ahmad, et al.
Publicado: (2020)

Treatment Status and Healthcare Cost Trends for Patients with Multiple Sclerosis in Japan: A Claims Database Analysis
por: Kawachi, Izumi, et al.
Publicado: (2022)

Healthcare Resource Utilization and Cost of Patients with Multiple Myeloma in Germany: A Retrospective Claims Data Analysis
por: Kocaata, Zeki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_klsvk50akib89jqbvf5uf29jsd